A Deep Dive Into Vitiligo and Its Associated Comorbidities

Seemal Desai, MD, Associate Professor of Clinical Dermatology at the University of Texas-Southwestern in Dallas, TX, and Founder of Innovative Dermatology in Plano, TX, and Andrew F. Alexis, MD, MPH, Professor of Clinical Dermatology and Vice-Chair for Diversity and Inclusion at Weill Cornell Medicine in New York, NY, discuss classic vitiligo comorbidities including autoimmune thyroid disorders, diabetes, rheumatoid arthritis, and pernicious anemia as well as underlying dermatologic diseases. They also review common lab abnormalities and share their lab screening protocols for patients with vitiligo. This don’t-miss episode of Prescribing Hope wraps with a discussion on challenging vitiligo cases.

Keeping the Color: Maintenance Strategies After Vitiligo Repigmentation
The Evolution of Vitiligo Treatment: From Steroids and Broad Immunosuppression to Targeted JAK Inhibition
Hope on the Horizon: Ushering in the New Era in the Management of Vitiligo
Of Patients and Patience in Vitiligo: The Importance of Managing Treatment Expectations
It’s a Marathon, Not a Sprint: Achieving Repigmentation in Vitiligo With Topical JAK Inhibitors

About This Educational Video Series

This educational video series provides expert commentary on the current treatment landscape for patients with vitiligo.